medigraphic.com
ISSN 0016-3813 (Print)

2014, Number s3

<< Back Next >>

Gac Med Mex 2014; 150 (s3)

Evolution of pediatric patients with liver transplantation in a tertiary care hospital in northeast country

Castilla VMP, Méndez RY, Palacios-Saucedo GC

Language: Spanish
References: 25
Page: 282-287
PDF size: 272.42 Kb.


ABSTRACT

Introduction: Liver transplantation is indicated for the treatment of pediatric patients with progressive liver disease in which an expected survival of less than a year would be achieved with the transplant. The aim of this study was to determine the evolution of pediatric liver transplant patients in a tertiary care hospital in the northeast country. Results: Twelve patients subjected to liver transplantation included nine females and three males; one case required retransplantation. Age at transplantation was 3.3 years (range 0.11-14). The weight at transplantation was 12.4 kg (5.7-35.5). The most common indication for transplantation was biliary atresia in six patients (50%). According to the type of graft, 12 (92.3%) were from cadaveric donors, of which seven were segmental. The most common complications were infectious ones in nine patients (75%); surgical complications occurred in eight children (66.6%), with immediate postoperative bleeding in five cases (41.6%). The three-year survival in the entire series was 50%. Conclusions: This study demonstrates that pediatric liver transplantation is possible in this institution, with a better survival expectancy of patients in the future.


REFERENCES

  1. Orozco-Zepeda H. Editorial. Un poco de historia sobre el trasplante hepático. Rev Invest Clin. 2005;57(2):124-8.

  2. Otte JB. History of pediatric liver transplantation. Where are we coming from? Where do we stand? Pediatr Transplant. 2002;6(5):378-87.

  3. Varela-Fascinetto G. Trasplante de hígado en niños. Revista del Centro Nacional de Trasplantes. 2005;5:24-6.

  4. Shneider BL, Suchy FJ, Emre S. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003- 2004). Liver Transpl. 2006;12(1):40-5.

  5. Neto JS, Carone E, Pugliese RP, et al. Modified pediatric end-stage liver disease scoring system and pediatric liver transplantation in Brazil. Liver Transpl. 2010;16(4):426-30.

  6. Varela-Fascinetto G, Davila R, Hernandez A, Castañeda P, Fuentes V, Nieto J. Trasplante hepático en niños. Rev Invest Clin. 2005;57(2):273-82.

  7. 7 Prieto M, Clemente G, Casafont F, et al. Documento de consenso de indicaciones de trasplante hepático. Gastroenterol Hepatol. 2003;26(6):355-75.

  8. Adam R, McMaster P, O’Grady J, et al. European Liver Transplant Registry Report. Liver Transplantation. 2003;9(12):1231-43.

  9. Diliz-Pérez HS, Rossano A, García L, et al. Reporte del primer caso de trasplante hepático ortotópico en el Hospital General de México. Rev Med Hosp Gen Mex. 2013;76(1):34-40.

  10. Ruf AE, Villamil FG. Indicaciones y oportunidad del trasplante hepático. Acta Gastroenterol Latinoam. 2008;38(1):75-88.

  11. Ciocca M, Moreira-Silva SF, Alegría S, et al. Hepatitis A as an etiologic agent of acute liver failure in Latin America. Pediatr Infect Dis J. 2007;26(8):711-5.

  12. Matesanz R, de la Rosa G. Liver transplantation: The Spanish experience. Digestive and Liver Disease Supplements. 2009;3:75-81.

  13. Díaz C, Gámez M, de la Vega A, Frauca E. Trasplante hepático: indicaciones, técnicas quirúrgicas, complicaciones y tratamiento. An Pediatr (Barc). 2004;60(1):42-55.

  14. Buckel E, Alba G. Dieciséis años de experiencia de trasplante hepático en clínica Los Condes. Rev Med Clin Condes. 2010;21(2):267-72.

  15. Settmacher U, Theruvath, Pascher A, Neuhaus P. Living donor liver transplantation- European experiences. Nephrol Dial Transplant. 2004;19(suppl 4):iv16-21.

  16. Varela-Fascinetto G, Hernández A, Nieto J, et al. Trasplante hepático HIM Federico Gómez. Rev Invest Clin. 2011;63(supl. 1): 57-61.

  17. Cuarterolo M, Ciocca M, Lopez S, et al. Evolución de niños posttrasplante hepático luego del primer año de sobrevida. Medicina (B Aires). 2005;65(5):402-8.

  18. Hepp J, Zapata R, Buckel E, et al. Trasplante hepático en Chile: Aspectos generales, indicaciones y contraindicaciones. Rev Med Chile. 2008;136:793-804.

  19. Sokal EM, Goldstein D, Ciocca M, et al. End-stage Liver Disease and Liver Transplant: Current Situation and Key Issues. J Pediatr Gastroenterol Nutr. 2008;47(2):240-6.

  20. Lee Ng V, Fecteau A, Shepherd R, et al. Outcomes of 5-Year Survivors of Pediatric Liver Transplantation: Report on 461 Children From a North American Multicenter Registry. Pediatrics. 2008;122(6):e1128-35.

  21. McDiarmid SV. Management of the Pediatric Liver Transplant Patient. Liver Transpl. 2001;7(11):S77-86.

  22. Bucuvalas JC, Alonso E, Magee JC, Talwalkar J, Hanto D, Doo E. Improving long-term outcomes after liver transplantation in children. Am J Transplant. 2008;8(12):2506-13.

  23. Guariso G, Viso Dalla L, Manea S, et al. Italian experience of pediatric liver transplantation. Pediatr Transplant. 2007;11(7):755-63.

  24. Sociedad Española de Trasplante Hepático (SETH). Documento de consenso de la Sociedad Española de Trasplante. Listas de espera, trasplante pediátrico e indicadores de calidad. Gastroenterol Hepatol. 2009;32(10):702-16.

  25. Limbers C A, Neighbors K, Martz K, et al. Health-related quality of life in pediatric liver transplant recipients compared to other chronic disease groups. Pediatr Transplant. 2011;15(3):245-53.




2020     |     www.medigraphic.com